Moleculin Announces Annamycin Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas
HOUSTON, Dec. 29, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage...
Search
- Dec 28, 2020
- 4 min
CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent FDA Approval of IND Application
HOUSTON, Dec. 28, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), a biopharmaceutical company...
- Dec 23, 2020
- 3 min
Atari Founder & Technology Innovator Nolan Bushnell Joins Esports Technologies as Strategic Advisor
Company Continues Expansion With Addition of Atari Founder and First Tech Incubator; Two Top Executives LAS VEGAS, Dec. 23, 2020...
- Dec 18, 2020
- 2 min
CNS Pharmaceuticals Call to Discuss FDA IND Approval and Phase 2 Trial for Berubicin Today at 8:30am
HOUSTON, Dec. 18, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company...
- Dec 18, 2020
- 5 min
Logiq Begins Next Phase of Micro-Lending Program Designed to Provide Mobile Fintech Services to
5 Million Contract and Delivery Drivers NEW YORK, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Logiq, Inc. (OTCQX: LGIQ), a global provider of...
- Dec 18, 2020
- 5 min
Logiq Launches Pilot Program to Provide Mobile Fintech Services in Exclusive Strategic Alliance with
Indonesian National Cooperative, KMSB NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Logiq, Inc. (OTCQX: LGIQ), a global provider of...
- Dec 17, 2020
- 4 min
CNS Pharmaceuticals Announces FDA Approval of IND Application
for its Brain Cancer Drug Candidate Berubicin IND Approval Marks Key Step in Beginning of Potentially Pivotal Trial of Berubicin HOUSTON,...
- Dec 17, 2020
- 4 min
Moleculin Announces FDA Permission to Begin Clinical Study of Annamycin for Sarcoma Lung Metastases
HOUSTON, Dec. 17, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage...
- Dec 14, 2020
- 2 min
Boxlight Wins Best of Show Awards at ISTE
LAWRENCEVILLE, Ga.--(BUSINESS WIRE)--Boxlight Corporation (Nasdaq: BOXL), a leading provider of interactive technology, digital signage...
- Dec 7, 2020
- 2 min
Boxlight Announces Three New Product Awards
LAWRENCEVILLE, Ga.--(BUSINESS WIRE)--Boxlight Corporation (Nasdaq: BOXL), a leading provider of interactive technology, digital signage...
- Dec 3, 2020
- 3 min
Moleculin To Present Antitumor Activity of Annamycin in Combination with Ara-C
in AML at American Society for Hematology Annual Conference HOUSTON, Dec. 3, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX)...
- Dec 3, 2020
- 5 min
StereoVision Imaging, Industry Leader in 4D FMCW LiDAR Technology, Adds Five New Continuation Patent
to Extensive IP Portfolio CALABASAS, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- StereoVision Imaging, Inc. (SVI) has been granted four new...
- Dec 2, 2020
- 1 min
Logiq Is Full Of Interesting Growth And Synergy Opportunities
Source: https://seekingalpha.com/article/4392625-logiq-is-full-of-interesting-growth-and-synergy-opportunities
- Dec 1, 2020
- 3 min
Moleculin Announces FDA Approves 3 Rare Pediatric Disease Designations for WP1066
Priority Review Vouchers subject to approved NDA HOUSTON, Dec. 1, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin...
- Dec 1, 2020
- 6 min
QCI and Meraglim Join Forces to Deliver Capital Markets Risk Analysis Powered by QCI’s Mukai Quantum
LEESBURG, Va., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Quantum Computing Inc. (OTCQB: QUBT) (QCI), the technology leader in quantum-ready...
- Nov 24, 2020
- 5 min
CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent Announcements
for Glioblastoma Multiforme (GBM) Therapy HOUSTON, Nov. 24, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc....
- Nov 19, 2020
- 4 min
Moleculin Announces New Data Demonstrating Synergistic Antitumor Activity of Annamycin Combination
with Ara-C in AML Experimental data to be presented at American Society for Hematology Annual Conference HOUSTON, Nov. 19, 2020...
- Nov 19, 2020
- 5 min
CNS Pharmaceuticals (NASDAQ: CNSP) Outlines Plans for Advancing Drug It Hopes Will Beat Deadly Brain
November 19, 2020 Biotechnology developer CNS Pharmaceuticals is working to advance the clinical trials of a novel brain cancer-fighting...
- Nov 19, 2020
- 2 min
CNS Pharmaceuticals and WPD Pharmaceuticals to Contribute Sponsorship to 2020 SNO Virtual Meeting
HOUSTON, Nov. 19, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company...
- Nov 19, 2020
- 3 min
Boxlight Announces Mark Starkey as President
LAWRENCEVILLE, Ga.--(BUSINESS WIRE)--Boxlight Corporation (Nasdaq: BOXL), a leading provider of interactive technology solutions, today...